Mice Ideas

Inaugural Function - Best of ASTRO - 15 Aug 2020

Day 1 - Best of ASTRO - 15 Aug 2020

Session 1 - Breast Cancer - 15 Aug 2020

Part 1 - Introduction - Dr G V Giri

Part 2 - Impact of Adjuvant Trastuzumab on Locoregional Failure Rate in the NCCTG-Dr Pooja

Part 3 - Cosmetic Outcome from Post Lumpectomy WBI Versus PBI on the NRG Oncology - Dr Pooja Iyer

Part 4 - A Prospective Phase l trial of CIS and RT in Women with Stage ll and lll TNBC - Dr Nidhi

Part 5 - Post Mastectomy Radiation Therapy in HER2/neu Positive Breast Cancer - Dr Nidhi Gupta

Part 6-Impact of Regional Lymph Node Irradiation on Lymphedema Risk in Breast Cancer Patient-Dr Neha

Part 7 - Prospective Phase ll Clinical Trial of Hypofractionated Radiation in Breast Cancer- Dr Neha

Part 8 - Discussion (Coordinator discuss the abstracts presented with experts)

Session 2 - Central Nervous System - 15 Aug 2020

Part 1: Prospective Phase l Dose Escalation Study for Neoadjuvant Radiosurgery - Dr Parneet Singh

Part 2-Significant Preservation of NCF and Patient-Reported Symptoms with HA during WBRT- Dr Parneet

Part 3 -A Single Blind Randomized Controlled Trial of HA on Neurocognitive Outcomes - Dr Rakesh

Part 4 - Leucencephalopathy after Prophylactic Whole Brain Irradiation - Dr Rakesh Ranjan

Part 5-Radiosurgery Compared To External Beam Radiotherapy for Localized Spine Metastasis-Dr Navneet

Part 6-Molecular Analysis within the High-risk Treatment Arms of NRG Oncology/RTOG 9802- Dr Navneet

Part 7 - Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab - Dr Sony Stephen

Part 8 - Microstructural Injury to Perisylvian - Dr Sony Stephen

Part 9 - Discussion (Coordinator discuss the abstracts presented with experts)

Session 3 - Gastrointestinal Cancer - 15 Aug 2020

Part 1 - A Pilot Study of Neoadjuvant FOLFIRINOX - Dr Garima Jaiswa, Varanasi

Part 2 - Patterns of Recurrence in the Critics Gastric Cancer Trial - Dr Garima Jaiswal, Varanasi

Part 3 - The Genomic Landscape of Anal Cancer and Its Relationship to Clinical Outcomes - Dr Ritika

Part 4 -ctDNA As a Potential Prognostic Marker for Locally Advanced Rectal Cancer Patients-Dr Ritika

Part 5 - PDO As the Potential Model to Predict Treatment Outcome of Rectal Cancer Patients -Dr Mayur

Part 6 -Improved Stratification for Risk of Early Metastases by Baseline Circulating Tumor -Dr Mayur

Part 7 - Multicenter Phase II Study of Stereotactic Ablative RadioTherapy - Dr Jaspinder Kaur

Part 8 -Evaluating the Impact of Nivolumab and Ipilimumab to Liver/Lung SBRT - Dr Jaspinder Kaur

Part 9 - Discussion (Coordinator discuss the abstracts presented with experts)

Session 4 - Genitourinary Cancer - 15 Aug 2020

Part 1 - Primary outcomes of a phase II randomized trial of Observation - Dr Rumita Singh

Part 2 - Hypo-Fractionation in Muscle-Invasive Bladder Cancer - Dr Rumita singh, Varanasi

Part 3 - A Phase III Multi-Centre Randomised Trial comparing adjuvant versus early salvage- Dr Sagar

Part 4 - Development and Validation of the First AJCC Compliant Clinical Staging System - Dr Sagar

Part 5-Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy- Dr Shashank

Part 6 - Two Years of Anti-Androgen Treatment Increases Other-Cause Mortality in Men - Dr Shashank

Part 7 - A Biochemical Definition of Cure Following Brachytherapy for Prostate Cancer - Dr Antara

Part 8-Patient Reported Acute Toxicity in PACE-B, an International Phase III Randomised - Dr Antara

Part 9 - Accelerating Prostate Stereotactic Ablative Body Radiotherapy (SABR) - Dr Deepak D. Ladia

Part 10 - High Dose-Rate Prostate Brachytherapy as Monotherapy - Dr Deepak D. Ladia

Part 11 - Discussion (Coordinator discuss the abstracts presented with experts)

Session 5 - Gynaecological Cancer - 15 Aug 2020

Part 1 - IMRT Improves Late Toxicity Compared to Conventional RT - Dr Shipra Garg

Part 2- Sexual Activity and Vaginal Functioning in Patients with Advanced Cervical Cancer- Dr Shipra

Part 3 - Improved Outcomes in the Modern Era with Multi-Modality Treatment - Dr Shreya Singh

Part 4 - Regional Control and Dose-Response for Chemoradiotherapy - Dr Shreya Singh, Varanasi

Part 5-Definitive External Beam Radiation Therapy With Stereotactic Body Radiation Therapy-Dr Ankita

Part 6 - Patterns of Recurrence and Survival in the Randomized Portec-3 - Dr Aditi Aggarwal, Delhi

Part 7 -Nomograms Predicting Overall Survival in Locally Advanced Cervical Cancer treated - Dr Aditi

Part 8 - Discussion (Coordinator discuss the abstracts presented with experts)

Session 6 - Head and Neck Cancer - 15 Aug 2020

Part 1-A Randomized Phase II Trial for Patients with Locoregionally Oropharyngeal Cancer- Dr Ankita

Part 2 - Randomized Clinical Trial on 7-days-a-week Postoperative Radiotherapy - Dr Bhanu

Part 3 - Randomized Clinical Trial on 7-days-a-week Postoperative Radiotherapy - Dr Bhanu

Part 4 - A Phase II Trial of AVOID - Dr Bhanu Vashistha, Ludhiana

Part 5 - Radiotherapy vs. Trans-Oral Robotic Surgery for OPSCC - Dr Abhirup Chandra, Rohtak

Part 6 - Recurrence and Quality-of-Life Following Elective Nodal Volume - Dr Abhirup Chandra, Rohtak

Part 7 - Reduction of Radiotherapy Dose to the Elective Neck in Head - Dr Praveen Ahlawat, Delhi

Part 8 - Stem Cell Sparing IMRT for Head and Neck Cancer Patients - Dr Praveen Ahlawat, Delhi

Part 9-Cost-Effectiveness of Screening for Nasopharyngeal Carcinoma - Dr Cessal Thommachan Kainickal

Part 10 - A Pilot Study of Stereotactic Body Radiotherapy - Dr Cessal Thommachan Kainickal

Part 11 - Discussion (Coordinator discuss the abstracts presented with experts)

Day 2 - Best of ASTRO - 16 Aug 2020

Session 7 - Hematologic Malignancies - 16 Aug 2020

Part 1 - PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma - Dr Neha Lall, Varanasi

Part 2 - Long-Term Outcomes for Patients With Limited Stage Follicular Lymphoma - Dr Neha Lall

Part 3 -Is Radiotherapy Adequate Treatment for Patients not in Complete Metabolic Response- Dr Divya

Part 4 - Patterns of Failure Following Chimeric Antigen Receptor T-cell (CAR-T) Therapy - Dr Divya

Part 5 - Patterns of Failure Following Chimeric Antigen Receptor T-cell (CAR-T) Therapy - Dr Divya

Part 6 - Quality of Life Improvement Following Low-Dose Total Skin Electron Beam Therapy - Dr Savita

Part 7 - Accelerated Fractionated Compared to Fractionated Salvage Radiation Therapy - Dr Savita

Part 8 - Discussion (Coordinator discuss the abstracts presented with experts)

Session 8 - Lung Cancer - 16 Aug 2020

Part 1 - Phase III Trial of Prophylactic Cranial Irradiation - Dr Poonam Sehar, Faridkot

Part 2 - A Prospective Single Arm Phase I/II Study - Dr Poonam Sehar, Faridkot

Part 3 - The Incidence and Location of Brain Metastases Following HA-PCI Compared - Dr Oshin Suri

Part 4 - A Prospective Phase II Radiation Dose-Escalation Study - Dr Oshin Suri

Part 5 - The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R) - Dr Abhishek Arora

Part 6 -Left Coronary Artery Dose Exposure Predicts Major Adverse Cardiac Event- Dr Pallavi Kalbande

Paert 7 - Discussion (Coordinator discuss the abstracts presented with experts)

Session 9 - Palliative Care - 16 Aug 2020

Part 1 - Pilot Assessment of the BMET Decision Support Platform - Dr Ayush Garg, Bareilly

Part 2 - Rapid Access Multidisciplinary Bone Metastases - Dr Ayush Garg, Bareilly

Part 3 -Trial of Single-Fraction versus Multi-Fraction Stereotactic Spine Radiosurgery - Dr Maninder

Part 4 - Improving the Palliative Patient Journey in Radiation Oncology - Dr Maninder Singh

Part 5 - Single-Fraction Stereotactic versus Conventional Multifraction Radiation - Dr Deepak

Part 6 -Quality of Life Outcomes after (SABR ) vs. Standard of Care Palliative Treatments- Dr Deepak

Part 7-Pre-Treatment and Early Post-Radiotherapy PET Metabolic Metrics Predict Probability-Dr Nilesh

Part 8 - A Volumetric Dosimetry Analysis of Vertebral Body Fracture Risk - Dr Nilesh Mani, Varanasi

Part 9 - Discussion (Coordinator discuss the abstracts presented with experts)

Session 10 - Patient Safety - 16 Aug 2020

Part 1 - Optimizing Efficiency and Safety in External Beam Radiotherapy - Dr Sarthak Tandon, Delhi

Part 2 - Quality Assurance of Contouring for NRG Oncology/RTOG 1308 Clinical Trial - Dr Sarthak

Part 3 - Reducing Treatment Delays with a Modified No-Fly Policy - Dr Samcy Arora, Jalandhar

Part 4 - Prospective Study of Problematic Plan Detection During Physician Chart Rounds - Dr Mathangi

Part 5 - Establishing a Radiation Oncology Quality Surveillance Program - Dr Mathangi J, Bangalore

Part 6 - Discussion (Coordinator discuss the abstracts presented with experts)

Part 7-EON Update on Recent Advancements of Nano-medicine in Cancer Theranostics - Anubhab Mukherjee

Session 11 - Radiation and Cancer Biology - 16 Aug 2020

Part 1 - Sensitive Detection of Microsatellite Instability (MSI) in Liquid Biopsies - Dr Avishek

Part 2 - Detectable HPV ctDNA in Post-Operative Oropharyngeal Squamous Cell Carcinoma - Dr Avishek

Part 3 - FOXO1 Inhibition as a Therapeutic Strategy for Radiation Fibrosis - Dr Shivani Mehra

Part 4 - De Novo Purine Synthesis Is a Targetable Vulnerability - Dr Shivani Mehra, Dehradun

Part 5 - VISTA Blockade Immunotherapy in a MULTI-Modal Approach to TNBC in MICE - Dr Amit Badola

Part 6 - Presence of Giant Circulating Cancer-Associated Macrophage-like Cells - Dr Amit Badola

Part 7 - Discussion (Coordinator discuss the abstracts presented with experts)

Session 12 - Radiation and Cancer Physics - 16 Aug 2020

Part 1 - The Low-Dose Bath Paradox - Dr Amandeep kaur, Ahmedabad

Part 2 - Habitat Evolution Imaging Biomarkers to Assess Early Response - Dr Balbir Singh, Bathinda

Part3-Acute Toxicity Patterns in Adaptive High Precision Radiotherapy for Head&Neck Cancer-Dr Balbir

Part 4 - Imaging-driven Biophysical Model for the Differentiation of Tumor Progression - Dr Kanchan

Part 5 - Effective Volume of Parotid Glands for Assessing Radiation Injury - Dr Ramita Sharma

Part 6 - Discussion (Coordinator discuss the abstracts presented with experts)